Aethlon Medical, Inc. AEMD

6.28 (0.49) (7.24%) as of 25 Sep
Market cap
$10.4M
P/E
0.0×
Growth Flags show if company had growth for consecutive years
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

(191.38%) (208.60%) (142.89%) (160.91%)
ROA
(139.25%) (158.03%) (104.46%) (120.22%)
ROIC
0.00% 0.00% 0.00% (1,665.51%)
Return on Tangible Assets
(209.94%) (182.35%) (159.65%) (142.51%)
Average Days of Receivables
0.00 — — —
Free Cash Flow per Share
(88.77) (42.15) (52.00) (18.70)
Free Cash Flow
(7.06) (6.94) (7.01) (7.20)
Capital Expenditures
— (0.02) (0.01) (0.02)
Other line items
Cash ROIC
(60.84%) (50.63%) (70.60%) (70.86%)
Accounts Receivable Turnover
0.00 — — —
Accounts Payable Turnover
0.00 0.00 0.00 0.00
Average Days of Payables
0.00 0.00 0.00 0.00
Tax Rate
0.00 0.00 0.00 0.00
Selling, General and Administrative Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Share Based Compensation of Revenue
0.00% 0.00% 0.00% 0.00%
Interest Coverage
0.00 0.00 0.00 0.00
Operating CF/Net income
0.63 0.60 0.98 1.04
Depreciation/Fixed assets
0.65 0.78 0.91 1.08
Capex/Depreciation
0.00 (0.05) (0.03) (0.05)
Revenue per Share
0.00 0.00 0.00 0.00
Operating CF per Share
(88.77) (42.04) (51.92) (18.66)
Capex per Share
0.00 (0.11) (0.08) (0.04)
Capex to Sales
— 0.00 0.00 0.00
Net Profit Margin
0.00% 0.00% 0.00% 0.00%

Fold the line items

Columns are period end dates